Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Keystone Symposium: Gut Microbiota Modulation of Host Physiology: The Search for Mechanism
The neuroendocrine axis in patients with multiple sclerosis.
Pregnancy and multiple sclerosis.
The MS Microbiome Consortium (MSMC): an academic multi-disciplinary collaborative effort to elucidate the role of the gut microbiota in MS
Episode 1 with Dr. Timothy Vollmer on maintaining brain health
Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects.
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KIT.
MHC transmission: insights into gender bias in MS susceptibility.
American Academy of Neurology: Breakthroughs in Neurology
Best practice in the use of natalizumab in multiple sclerosis.
17beta-estradiol and progesterone prevent cuprizone provoked demyelination of corpus callosum in male mice.
Environmental, modifiable risk factors for multiple sclerosis
Biogen Idec reports positive top-line results from Phase 2 anti-LINGO-1 trial in people with acute optic neuritis
Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.
Comparative efficacy of interferon β versus glatiramer acetate for relapsing-remitting multiple sclerosis.
Immunotherapies influence the influenza vaccination response in multiple sclerosis patients: an explorative study.
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System.
Episode 27 with Dr. Brenda Banwell on the new journal Multiple Sclerosis and Related Disorders
Cognitive Test Analysis May Determine Reliable MS Change Over Time
Cerebrospinal fluid data compilation and knowledge-based interpretation of bacterial, viral, parasitic, oncological, chronic inflammatory and demyelinating diseases. Diagnostic patterns not to be missed in neurology and psychiatry.
Keystone Symposium: Neuroepigenetics
A New Colour Reaction on Copper and Certain Carbonyl Compounds
Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
Sex differences in autoimmune disease.
Cerebellar cortical demyelination in the murine cuprizone model.
Pages
« first
‹ previous
…
51
52
53
54
55
56
57
58
59
…
next ›
last »